Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1344532rdf:typepubmed:Citationlld:pubmed
pubmed-article:1344532lifeskim:mentionsumls-concept:C0025202lld:lifeskim
pubmed-article:1344532lifeskim:mentionsumls-concept:C0026724lld:lifeskim
pubmed-article:1344532pubmed:issue3lld:pubmed
pubmed-article:1344532pubmed:dateCreated1994-5-12lld:pubmed
pubmed-article:1344532pubmed:abstractTextThe study of ENT mucous melanomas (ENT MM) was performed retrospectively, based on 20 patients treated in Bordeaux and 156 detailed files taken from the international literature. Each paragraph is followed by a review of the general literature. The ENT MM, a rare form of melanomas, presents a majority of nasal locations. The mean age is 63 years old. The sex ratio trend is towards one. The aspecific call signs partially explain the delayed diagnosis. The difficult pathological examination is assisted by tumoral markers. Mean survival is two and a half years without any clear prognostic factors as for cutaneous melanomas. Treatment is essentially surgical, but adjuvant radiotherapy may have a significant effect. The other treatments are palliative.lld:pubmed
pubmed-article:1344532pubmed:languagefrelld:pubmed
pubmed-article:1344532pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1344532pubmed:citationSubsetIMlld:pubmed
pubmed-article:1344532pubmed:statusMEDLINElld:pubmed
pubmed-article:1344532pubmed:issn0035-1334lld:pubmed
pubmed-article:1344532pubmed:authorpubmed-author:DelaunayM MMMlld:pubmed
pubmed-article:1344532pubmed:authorpubmed-author:TraissacLLlld:pubmed
pubmed-article:1344532pubmed:authorpubmed-author:MarkHHlld:pubmed
pubmed-article:1344532pubmed:authorpubmed-author:StollDDlld:pubmed
pubmed-article:1344532pubmed:issnTypePrintlld:pubmed
pubmed-article:1344532pubmed:volume113lld:pubmed
pubmed-article:1344532pubmed:ownerNLMlld:pubmed
pubmed-article:1344532pubmed:authorsCompleteYlld:pubmed
pubmed-article:1344532pubmed:pagination179-83lld:pubmed
pubmed-article:1344532pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:meshHeadingpubmed-meshheading:1344532-...lld:pubmed
pubmed-article:1344532pubmed:year1992lld:pubmed
pubmed-article:1344532pubmed:articleTitle[Melanoma of the ORL mucosa].lld:pubmed
pubmed-article:1344532pubmed:affiliationC.H.U. Pellegrin Tripode, Clinique ORL, Bordeaux, France.lld:pubmed
pubmed-article:1344532pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1344532pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:1344532pubmed:publicationTypeReviewlld:pubmed
pubmed-article:1344532pubmed:publicationTypeCase Reportslld:pubmed